Dr Richard Halvorsen

offering vaccine choice

Delaying vaccination reduces risk of eczema

New research has found that the risk of a child developing eczema is reduced by half if the start of vaccination is delayed by at least one month. Most Australian children start their DTaP schedules at two months of age, usually with a 6-in-1 DTaP-IPV-Hib-HB vaccine. Those who did not have the first one of these until three months or later were 43% less likely to have a diagnosis of eczema and 55% less likely to be using eczema medication.
This follows previous research that found that the risk of a child developing asthma was reduced by over half when vaccination was delayed until five months of age.